Member Info for Chelsea11

Better than adequate imo. It fully backs up the strong HY Results issued in December and they remain on track to becoming a £200M business. It isn’t long to wait until May for FY Results if the SP doesn’t move north on todays announcement.

Yes they make a difference Bojo but they are behind the principal reasons I describe in respect of Scancell specifically. Seems my view is clearly shared by others here.

Many shares are consistently rising, despite what Putin and Trump are up to. Why do you think that might be?

Absolutely nothing to do with Trump & Putin imo and everything to do with not enough data to excite the market, or cash in the bank from deals - yet.

Harry Houdini - Cleaner stated “seems to be trial locations in the US, please can someone take a look”

So I took a look and responded that there are no trial locations in the US ie. it was all an illusion 😂

To clarify then, some photos that are 9 months old and a static picture of the US 🙄

So which trial sites in the US are you seeing then Cleaner, after following the instructions you have taken the trouble to set down?

I’m not seeing any. Just the 15 in the UK.

Cleaner - 9 months old and no US locations listed amongst the 15 trial sites. Where are you looking?

AACR IO on 25/02, the first of many opportunities likely coming up very soon, based on past form. As Scinv highlights, substantially more data and confidence this year.

March 2024 was a very busy month for conference attendance / presentation.

- Next Gen Immuno-Oncology

- World ADC

- Oxford Global - Biologics

· BIO-Europe Spring

Reasonable to think some / all will be attended this year also. With personnel changes, perhaps opportunities for more commercially biased conversations this time around. I’d expect RNS confirmation of attendance & content in due course.

As for the headline of “Patience, Persistence and Perseverance” applying to Scancell indicated by Cleaner, well yes true but equally so for thousands of other biotech companies around the globe and all of their investors. Simply a given.

The headline of “Genmab up over 8%” is pretty meaningless here, as is the constant blizzard of links to Genmab every time they break wind. Doesn’t help anyone imo.

Commentary from Scancell on Genmab is what is needed. We have had that historically and we will receive it again in future. Anything else is 2+2=5.

I cannot see Genmab bidding to buy the whole company. Perhaps any/all antibody therapeutic elements that align to their clear strategic direction could attract a bid in future but very much doubt lock, stock & barrel.

And so obviously true.

Yet another Genmab cross-ramp from Cleaner.

Very useful for all Genmab investors.

Cleaner - Yahoo Finance and others like TipRanks are jammed full of crap and clickbait. That isn’t research.

In addition why do you think every article ever written about Genmab should reference Scancell? Yes they have a collaboration but so do many other companies, with much bigger potential deals in play and also further advanced.

What AI struggles with are social skills, emotional intelligence, and interpersonal relationships.

AI could plug in here for a week and problem solved 😂

March 2024 was a very busy month for conference attendance / presentation.

- Next Gen Immuno-Oncology

- World ADC

- Oxford Global - Biologics

· BIO-Europe Spring

Reasonable to think some / all will be attended this year also. With personnel changes, perhaps opportunities for more commercially biased conversations this time around. I’d expect RNS confirmation of attendance & content in due course.

HAGW!

I’m not convinced there will be a knock on the door in the short term (this year) from anyone wanting to pick up the whole company, or as EE says, offering a high enough price. I think that’s more likely to happen in 2026 and may also only be for a part of Scancell that fits well to the acquirers business.

Been thinking about the Christian Ottensmeier quote in the Interims.

“Given its good safety profile and ease of use, I remain keen to continue using this vaccine as well as explore the application of Modi-1 in the neoadjuvant setting."

Could neoadjuvant setting approval by MHRA be upcoming news in Q1?

It gets on my tits when someone doesn’t read something carefully.

😂

BOJO - this is the biggest load of total crap I’ve seen here in recent months.

“ If I was him I would be contacting you all right now and saying. "Hey, you lot! How are you doing? What's your name? How long have you been holding? Wow that's a long time, you must have seen a few things. So what can you tell me about holding all those years? Anyway, just wanted to say that I admire you holding through all this time. You must be bloody loyal! Seriously well done. I for one appreciate you holding all this time and always believing. I am gonna make sure that its worth it”